🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
12/03/2015 0,4294 USD
11/12/2014 0,4294 USD
11/09/2014 0,4198 USD
12/06/2014 0,4198 USD
13/03/2014 0,4198 USD
12/12/2013 0,4198 USD
12/09/2013 0,4103 USD
13/06/2013 0,4103 USD
13/03/2013 0,4103 USD
13/12/2012 0,4103 USD
13/09/2012 0,4008 USD
13/06/2012 0,4008 USD
13/03/2012 0,4008 USD
13/12/2011 0,4008 USD
13/09/2011 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/12/1984 2,47 2,49 2,47 2,49 +0,81% 1,08% 4.180.262
28/12/1984 2,46 2,48 2,46 2,47 +0,67% 0,68% 4.474.541
27/12/1984 2,45 2,47 2,45 2,46 +0,13% 0,81% 5.889.341
26/12/1984 2,46 2,47 2,45 2,45 -0,54% 0,68% 3.795.437
24/12/1984 2,45 2,48 2,45 2,47 +1,09% 1,62% 6.670.310
21/12/1984 2,45 2,45 2,42 2,44 -0,27% 1,35% 9.167.904
20/12/1984 2,47 2,47 2,44 2,45 -0,81% 1,21% 4.689.590
19/12/1984 2,46 2,49 2,46 2,47 +0,27% 1,48% 12.533.242
18/12/1984 2,41 2,46 2,41 2,46 +2,06% 1,92% 10.967.530
17/12/1984 2,39 2,42 2,39 2,41 +1,11% 1,38% 8.349.206
14/12/1984 2,36 2,40 2,36 2,38 +0,84% 1,54% 7.722.922
13/12/1984 2,37 2,38 2,36 2,36 -0,42% 0,98% 7.919.107
12/12/1984 2,36 2,38 2,35 2,37 +1,13% 1,12% 7.673.875
11/12/1984 2,35 2,36 2,34 2,35 +0,00% 0,57% 11.695.680
10/12/1984 2,34 2,36 2,34 2,35 +0,14% 0,71% 5.319.648
07/12/1984 2,35 2,35 2,34 2,34 -0,14% 0,57% 3.440.794
06/12/1984 2,33 2,35 2,33 2,35 +0,42% 1,14% 3.961.440
05/12/1984 2,35 2,35 2,33 2,34 -0,57% 0,71% 3.576.614
04/12/1984 2,34 2,35 2,33 2,35 +1,00% 0,99% 6.104.390
03/12/1984 2,34 2,34 2,33 2,33 -1,13% 0,71% 3.572.842
30/11/1984 2,35 2,37 2,35 2,35 -0,42% 0,85% 4.670.726
29/11/1984 2,37 2,37 2,35 2,36 -0,42% 0,98% 9.579.139
28/11/1984 2,41 2,41 2,37 2,37 -1,92% 1,52% 9.326.362
27/11/1984 2,36 2,42 2,36 2,42 +2,38% 2,53% 11.084.486
26/11/1984 2,37 2,38 2,35 2,36 -0,70% 1,12% 3.259.699
23/11/1984 2,35 2,39 2,35 2,38 +1,13% 1,41% 8.481.254
21/11/1984 2,31 2,36 2,31 2,35 +1,58% 2,15% 3.123.878
20/11/1984 2,29 2,32 2,29 2,32 +1,74% 1,30% 3.893.530
19/11/1984 2,28 2,28 2,27 2,28 +0,73% 0,73% 2.788.099
16/11/1984 2,28 2,30 2,26 2,26 -1,30% 1,74% 7.900.243